Fetal nuchal translucency and normal chromosomes: A long-term follow-up study

Ultrasound in Obstetrics and Gynecology

Volumn 18, Issue 1, 2001, Pages 18-22

  Hiippala, A ^a   Eronen, M ^a   Taipale, P ^b   Salonen, R ^c   Hiilesmaa, V ^c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Congenital heart disease; Nuchal translucency; Screening; Sonography

Indexed keywords

ARTICLE; CONGENITAL HEART DISEASE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FETUS; FETUS ECHOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; POSTNATAL DEVELOPMENT; PRENATAL DIAGNOSIS; PRIORITY JOURNAL;

CHILD; CHILD DEVELOPMENT; FEMALE; FETAL DISEASES; FOLLOW-UP STUDIES; HEART DEFECTS, CONGENITAL; HUMANS; MALE; NECK; PREGNANCY; PROGNOSIS; ULTRASONOGRAPHY, PRENATAL;

EID: 0034913621     PISSN: 09607692     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0705.2001.00481.x     Document Type: Article

References (17)

1. UK multicentre project on assessment of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation
2. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation
3. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: Population based cohort study
4. Increased nuchal translucency as a marker for fetal chromosomal defects
5. Dimensions of the heart and great vessels in normal children
6. Cardiac structure growth pattern determined by echocardiography
7. New format for a growth chart
8. Report of the Second Task Force on Blood Pressure Control in Children - 1987. Task Force on Blood Pressure Control in Children
9. Prevalence of articulatory speech disorders of different sounds in a group of Finnish first-graders
10. Congenital heart disease. Antenatal diagnosis of heart disease
11. Outcome of fetuses with heart disease diagnosed in utero
12. Outcome of chromosomally normal livebirths with increased fetal translucency at 10-14 weeks' gestation
13. Nuchal translucency and congenital heart defects: Heart failure or not?
14. Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation
15. Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects
16. Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses
17. The prognosis of fetuses with transient nuchal translucency in the first and early second trimester